Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-04 Esposito Pamela Chief Business Officer Sale −4,200 $35.00 $147K 210,159
2021-08-04 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −4,200 71,550
2021-07-21 Esposito Pamela Chief Business Officer Option exercise +12,538 $1.01 $13K 222,697
2021-07-21 Esposito Pamela Chief Business Officer Sale −12,538 $33.17 $416K 210,159
2021-07-21 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −12,538 51,203
2021-07-20 Esposito Pamela Chief Business Officer Option exercise +4,862 $1.01 $5K 215,021
2021-07-20 Esposito Pamela Chief Business Officer Sale −4,862 $33.05 $161K 210,159
2021-07-20 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −4,862 63,741
2021-07-15 Esposito Pamela Chief Business Officer Option exercise +4,600 $1.01 $5K 214,759
2021-07-15 Esposito Pamela Chief Business Officer Sale −4,600 $33.37 $154K 210,159
2021-07-15 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −4,600 68,603
2021-07-15 Love Colin Chief Operating Officer Sale −30,000 $32.02 $961K 835,809
2021-07-02 Coffin Robert President & Chief R&D Officer Sale −7,810 $40.04 $313K 1,775,684
2021-06-29 Coffin Robert President & Chief R&D Officer Sale −22,826 $40.05 $914K 1,783,494
2021-06-28 Coffin Robert President & Chief R&D Officer Sale −14,663 $40.04 $587K 1,806,320
2021-06-15 Love Colin Chief Operating Officer Sale −17,800 $33.80 $602K 878,009
2021-06-15 Love Colin Chief Operating Officer Sale −12,200 $34.53 $421K 865,809
2021-05-10 Lewis Tanya Chief Dev. Oper. Off. Grant or award +73,333 73,333
2021-05-10 Lewis Tanya Chief Dev. Oper. Off. Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2021-05-03 Patel Sushil Chief Commercial Officer Grant or award +88,333 88,333

Page 13 of 19 · 365 trades